Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher O'Connor

Showing results (101-110 of 133) with videos related to

Pageof 14
Sort By:
The Journal of Clinical Investigation|August 15, 2022
Upregulated PD-1 signaling antagonizes glomerular health in aged kidneys and diseaseJeffrey W Pippin, Natalya Kaverina, Yuliang Wang, et al.
The New England Journal of Medicine|March 12, 2013
Treatment of anemia with darbepoetin alfa in systolic heart failureKarl Swedberg, James B Young, Inder S Anand, et al.
European Journal of Heart Failure|November 19, 2016
Rationale for and design of the TRUE-AHF trial: the effects of ularitide on the short-term clinical course and long-term mortality of patients with acute heart failureMilton Packer, Richard Holcomb, William T Abraham, et al.
Circulation. Heart Failure|August 8, 2020
Representation of Women Authors in International Heart Failure Guidelines and Contemporary Clinical TrialsNosheen Reza, Ayman Samman Tahhan, Nadim Mahmud, et al.
Circulation|February 11, 2009
Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trialInder S Anand, Peter Carson, Elizabeth Galle, et al.
European Journal of Heart Failure|July 28, 2009
Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trialJohn J V McMurray, Inder S Anand, Rafael Diaz, et al.
Journal of the American College of Cardiology|February 19, 2025
Standardized Definitions of Changes in Kidney Function in Trials of Heart Failure: JACC Expert Panel From the HF-ARCAnuradha Lala, Steven Coca, Jason Feinman, et al.
European Journal of Heart Failure|March 29, 2019
Clinical factors related to morbidity and mortality in high-risk heart failure patients: the GUIDE-IT predictive model and risk scoreChristopher O'Connor, Mona Fiuzat, Hillary Mulder, et al.
JACC. Heart Failure|April 28, 2023
Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure: The GUIDE-IT TrialMuhammad Shahzeb Khan, Sumitabh Singh, Matthew W Segar, et al.
JCI Insight|January 11, 2019
Organoid single cell profiling identifies a transcriptional signature of glomerular diseaseJennifer L Harder, Rajasree Menon, Edgar A Otto, et al.
Pageof 14

Showing results (101-110 of 133) with videos related to

Sort By:
Pageof 14
The Journal of Clinical Investigation|August 15, 2022
Upregulated PD-1 signaling antagonizes glomerular health in aged kidneys and diseaseJeffrey W Pippin, Natalya Kaverina, Yuliang Wang, et al.
The New England Journal of Medicine|March 12, 2013
Treatment of anemia with darbepoetin alfa in systolic heart failureKarl Swedberg, James B Young, Inder S Anand, et al.
European Journal of Heart Failure|November 19, 2016
Rationale for and design of the TRUE-AHF trial: the effects of ularitide on the short-term clinical course and long-term mortality of patients with acute heart failureMilton Packer, Richard Holcomb, William T Abraham, et al.
Circulation. Heart Failure|August 8, 2020
Representation of Women Authors in International Heart Failure Guidelines and Contemporary Clinical TrialsNosheen Reza, Ayman Samman Tahhan, Nadim Mahmud, et al.
Circulation|February 11, 2009
Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trialInder S Anand, Peter Carson, Elizabeth Galle, et al.
European Journal of Heart Failure|July 28, 2009
Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trialJohn J V McMurray, Inder S Anand, Rafael Diaz, et al.
Journal of the American College of Cardiology|February 19, 2025
Standardized Definitions of Changes in Kidney Function in Trials of Heart Failure: JACC Expert Panel From the HF-ARCAnuradha Lala, Steven Coca, Jason Feinman, et al.
European Journal of Heart Failure|March 29, 2019
Clinical factors related to morbidity and mortality in high-risk heart failure patients: the GUIDE-IT predictive model and risk scoreChristopher O'Connor, Mona Fiuzat, Hillary Mulder, et al.
JACC. Heart Failure|April 28, 2023
Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure: The GUIDE-IT TrialMuhammad Shahzeb Khan, Sumitabh Singh, Matthew W Segar, et al.
JCI Insight|January 11, 2019
Organoid single cell profiling identifies a transcriptional signature of glomerular diseaseJennifer L Harder, Rajasree Menon, Edgar A Otto, et al.
Pageof 14